U.S. lawmakers push Mylan, Teva over drug pricing probe

The head of the U.S. House of Representative’s oversight panel on Wednesday called on three drugmakers to turn over documents as part of an ongoing congressional review over generic drug price increases and accused the companies of “apparent efforts to stonewall” the probe.


Source: Reuters Health

Be the first to comment

Leave a Reply

Your email address will not be published.


*